In AD, the concentration of CSF Aβ1–42 is decreased, which is supposed to reflect sequestration of Aβ1–42 in amyloid plaques in the brain [6], while t-tau and p-tau levels are increased [1]. The gene discussed is MAPT; the disease is Alzheimer disease.